A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
By Robert Risinger, Marjie Hard, Peter J. Weiden
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
By John M. Kane, Christoph U. Correll, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
By Christoph U. Correll, Richard C. Josiassen, Grace S. Liang, Joshua Burke, Christopher F. O’Brien
Treatment of Autism Spectrum Disorder in Children and Adolescents
By Melissa DeFilippis, Karen Dineen Wagner
EVIDENCE-BASED MEDICINE
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
By Patricia Berney, Demian Halperin, Rodrigo Tango, Isabelle Daeniker-Dayer, Pierre Schulz
Artículo original
Estudio de validación de la Escala de Salud Personal (ESP) en Lima, Perú
Dra. María Isabel Zapata-Vega, Dr. Juan Enrique Mezzich, Dr. Guido Mazzotti, Dr. Robert De la Grecca, Dr. Jean-Pierre Llanos y Dra. Juana Hernández
Efficacy and Tolerability of Controlled-Release Paroxetine
By Robert N. Golden, MD